Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

Clinical trial NCT00109655 · UNKNOWN

Trial details

NCT number: NCT00109655
Sponsor: Cell Genesys
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Transitional Cell Bladder Neoplasms

Start date: 2005-04-01
Primary completion: 2008-10-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.